Current Price: ₹1869.30
Target: ₹2050+
Entry Range: ₹1860 - ₹1885
Stop Loss: Below ₹1800
Indicators & Moving Averages:
The stock is trading above key exponential moving averages (21-day, 50-day, and 200-day), indicating strong momentum and bullish sentiment.
The 21-day EMA crossing above the 50-day EMA suggests an upward trend continuation, especially with the price bouncing from the support levels.
Support & Resistance:
Support: ₹1800, which acts as a critical level to prevent further downside.
Resistance: Around ₹2000 - ₹2050. Once this level is breached, further upside is expected.
Outlook:
Given the strength shown on the chart, with multiple indicators aligning to support the bullish view, Aavas Financiers could see an upward rally, provided market conditions remain favorable. The risk-reward ratio seems promising with a well-defined stop loss, making this a potentially attractive setup for swing traders.
Target: ₹2050+
Entry Range: ₹1860 - ₹1885
Stop Loss: Below ₹1800
Indicators & Moving Averages:
The stock is trading above key exponential moving averages (21-day, 50-day, and 200-day), indicating strong momentum and bullish sentiment.
The 21-day EMA crossing above the 50-day EMA suggests an upward trend continuation, especially with the price bouncing from the support levels.
Support & Resistance:
Support: ₹1800, which acts as a critical level to prevent further downside.
Resistance: Around ₹2000 - ₹2050. Once this level is breached, further upside is expected.
Outlook:
Given the strength shown on the chart, with multiple indicators aligning to support the bullish view, Aavas Financiers could see an upward rally, provided market conditions remain favorable. The risk-reward ratio seems promising with a well-defined stop loss, making this a potentially attractive setup for swing traders.
Started like everyone else — chasing trends, ignoring risk.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
Started like everyone else — chasing trends, ignoring risk.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.